ClinicalTrials.gg

Muscular Dystrophy, Duchenne clinical trials

The registry lists 481 studies for Muscular Dystrophy, Duchenne across more than 10 countries. 107 are recruiting or about to start. 448 of them are mainly about Muscular Dystrophy, Duchenne (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-12.

Get an email when these change. Save the Muscular Dystrophy, Duchenne studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
237
Recruiting
66
Terminated
53
Active, not recruiting
37
Status unknown
34
Not yet recruiting
21

Phase

Phase 2
141
Phase 1
93
Phase 3
59
Phase 4
10
Early Phase 1
9

Where

United States
232
United Kingdom
84
Italy
82
Turkey
67
France
66
Canada
65

What is being tested here

Drugs under test in Muscular Dystrophy, Duchenne studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

Drug classes tested here HDAC inhibitors 3 open · PDE5 inhibitors 1 open · Corticosteroids 1 open · Beta blockers 1 open · Mineralocorticoid receptor antagonists (MRAs) 3

Coming up

39studies finish main data collection within a year1 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 66 Muscular Dystrophy, Duchenne studies recruiting now, 30 (45%) set no upper age limit and 34 (52%) stop at 75 or younger. 60 (91%) take children under 18. 1 (2%) are for women only and 43 (65%) for men only; 12 (18%) take healthy volunteers.

Recruiting studies that take each age, of 66
AgeWomenMen
1018 (27%)47 (71%)
1821 (32%)46 (70%)
3020 (30%)37 (56%)
4019 (29%)35 (53%)
5019 (29%)34 (52%)
6519 (29%)32 (48%)
7518 (27%)31 (47%)
8517 (26%)30 (45%)

Across all 481 studies, recruiting or not: 66% stop at 75 or younger and 65% at 65; 90% take children; 1% are for women only and 76% for men only; 16% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Muscular Dystrophy, Duchenne studies take

Of 47 phase 2 interventional studies under Muscular Dystrophy, Duchenne, half reached primary completion within 31 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 119 mo11–35 · 28 studies——
Phase 1/250 mo24–63 · 23 studies——
Phase 231 mo20–42 · 47 studies31 mo20–42 · 40 studies—
Phase 354 mo38–73 · 26 studies——
Interventional, no phase20 mo10–44 · 47 studies—19 mo10–44 · 45 studies
Observational40 mo12–120 · 63 studies—37 mo11–120 · 52 studies

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 13, 2026.

Studies

Recruiting first, then most recently updated. Showing 50 of 481. Browse all 481 → or search them.